Cytotam Tamoxifen 20 Mg

Price range: $27 through $90

14 products sold in last 11 hours

Selling fast! Over 18 people have in their cart

Cytotam 20 mg is an oral tablet containing tamoxifen, a widely used selective estrogen receptor modulator. It binds to estrogen receptors in breast tissue, preventing estrogen from stimulating the growth of hormone‑receptor positive tumors. Indications include adjuvant therapy for early breast cancer, treatment of metastatic disease, and risk reduction in high-risk women.

Unit

120 Tablets150 Tablets300 Tablets90 Tablets

Clear

21 people are viewing this right now

Estimated Delivery : Up to 4 business days
Free Shipping & Returns : On all orders over $200

Guaranteed Safe And Secure Checkout

✅ Key Benefits

Blocks estrogen receptor activity, slowing tumor growth
Oral therapy, allowing home administration
Supported by decades of research for long-term cancer control
Proven to reduce recurrence and mortality in estrogen-positive cancers

🎯 How to Use

Typically taken as 20 mg once daily, with or without food
Swallow tablet whole with water
Continue treatment for 5 years or longer based on risk assessment
Routine monitoring recommended during therapy
If a dose is missed, take it when remembered (unless close to the next scheduled dose)

⚠️ Precautions

Prescription-only; requires oncologist oversight
Raises risk of uterine cancer and blood clots—monitor accordingly
Caution in patients with history of thromboembolic events
Inform doctor about liver problems, eye issues, or pregnancy
Regular gynecologic exams and periodic liver function tests are advised

🤕 Possible Side Effects

Common: Hot flashes, vaginal dryness or discharge
Gynecologic: Irregular menstruation (in premenopausal women), potential endometrial thickening
Thromboembolic: Deep vein thrombosis (DVT) and pulmonary embolism (rare)
Other: Mood changes, headache, nausea, weight changes
Serious (rare): Uterine cancer, stroke—seek immediate care for severe symptoms

❓ Frequently Asked Questions (FAQs)

Q. Who should use Cytotam?
A. Patients with estrogen receptor–positive breast cancer, either as adjuvant therapy or for metastatic treatment, and for risk reduction in high-risk individuals.

Q. How long should treatment continue?
A. Usually 5 years; longer durations (up to 10 years) may be recommended based on individual risk.

Q. How are side effects managed?
A. Regular screenings (gynecologic, liver monitoring) and proactive management of symptoms like hot flashes and clot risk help ensure safety.

Q. Can Cytotam be used with other therapies?
A. Yes, it’s often combined with ovarian suppression in premenopausal women or followed by aromatase inhibitors in postmenopausal women.